| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.2M | -10.5% |
| R&D Expense | $8.4M | -20.8% |
| SG&A Expense | $12.1M | +22.1% |
| Operating Income | -$15.3M | -4.1% |
| Pre-tax Income | -$22.4M | -72.5% |
| Income Tax | $0 | — |
| Net Income | -$22.4M | -72.5% |
| EPS (Basic) | -$0.29 | +85.1% |
| EPS (Diluted) | -$0.29 | +87.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.3M | +5500.0% |
| Short-term Investments | $4.4M | +23.4% |
| Current Assets | $15.2M | +188.5% |
| Total Assets | $16.3M | +146.1% |
| Current Liabilities | $12.3M | -20.8% |
| Total Liabilities | $12.3M | -20.9% |
| Stockholders' Equity | $4.0M | +144.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.8M | -96.8% |
| Capital Expenditures | $67K | -54.1% |
| Investing Cash Flow | -$854K | +79.2% |
| Financing Cash Flow | $30.3M | +389.9% |
| Free Cash Flow | -$20.8M | -94.8% |